Next Science | Investor Centre

Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary Xbio^TM technology to reduce the impact of biofilm based infections in human health.

Share Price Performance

Current share price (ASX: NXS)

0.57 -0.02
-2.6%

Updated 1:05PM 30/05/2023

Currency	AUD
Change (%)	-0.02 (-2.6%)
Volume	376,475

Today's Open	0.56
Intraday High	0.58
Intraday Low	0.56

Historical Share Price

Board Charter

Code of Conduct

Diversity Policy

Shareholder Communication Policy

Continuous Disclosure Policy

Security Trading Policy

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474